Michael A. Jenike - McLean Hospital - Harvard University

More documents

Recommendations

Info

12 1989- Director of Research Training, Department of Psychiatry, Massachusetts General Hospital 1989- Course Director, Methods of Psychiatric Research to Psychiatric Residents 1989- Journal Club Leader, Psychiatric Residents Sponsor, Massachusetts General Hospital Minority Recruitment Committee Summer Research Trainee Program 1992- Faculty Member, Harvard Medical School Postdoctoral Research Program in Training in Biological Psychiatry and Social/Developmental Psychiatry Principal Clinical and Hospital Service Responsibilities: 1981-1987 Co-Director, Cognitive Function (Dementia) Clinic, Massachusetts General Hospital, Boston, MA 1982-1987 Director, Inpatient Psychiatric Service, Massachusetts General Hospital, Boston, MA 1982- Director, Obsessive-Compulsive Disorders Clinic and Research Unit, Massachusetts General Hospital 1987- Research Psychiatrist, Massachusetts General Hospital 1989- Director of Research Training, Department of Psychiatry, Massachusetts General Hospital 1990-1994 Member, MGH Executive Committee on Research 1991- Associate Chief (Research), Department of Psychiatry, Massachusetts General Hospital 1995- Director, Psychiatric Neuroscience Program, Massachusetts General Hospital Department of Psychiatry 1996- Director, OCD Institute: Residential treatment facility for patients with treatment refractory obsessive compulsive disorder, McLean Hospital.
13 Funded Research Projects: Principal Investigator = M. Jenike. McIngvale Project to Cure OCD. 10/1/05 - 10/1/15. $10,000,000. Principal Investigator = M. Jenike. Sertraline and atypical neuroleptics in the treatment of patients with trichotillomania. $153,000 total costs over 2 years. 1/1/98-1/1/00. Principal Investigator = M. Jenike. OCD Institute: Residential treatment facility for patients with treatment refractory obsessive-compulsive disorder. $900,000 total costs over 3 years. 1/15/97-1/15/01. Principal Investigator = M. Jenike. NIMH: RO1 MH50275-03: Positron Emission Tomographic Activation Studies in Patients with Obsessive-Compulsive Disorders. $915,550 total costs over 4 years. 8/1/95-8/1/99. Principal Investigator = M. Jenike. Fluoxetine versus placebo in obsessivecompulsive disorder relapse prevention. Eli Lilly Pharmaceutical Company. $185,000. 8/1/95-8/1/97. Principal Investigator = M. Jenike. Beard Research Fund: A controlled trial of capsulotomy as treatment for refractory obsessive-compulsive disorder. $300,000. 1/31/95-1/31/00. Principal Investigator = M. Jenike. Umbach Research Fund: Research into obsessive-compulsive disorders. $50,000. 1997-1998. Principal Investigator = M. Jenike. David Judah Research Fund: Neural substrates for obsessive-compulsive disorder. $2,400,000. 7/1/93-6/31/06. Principal Investigator = M. Jenike. Bernard Adams Research Fund: Research into obsessive-compulsive disorders. $25,000. 1993-1996. Principal Investigator = M. Jenike. NIMH: 1 RO1 MH51261-01: A shamcontrolled study of capsulotomy for obsessive-compulsive disorder. $1,578,151 proposed direct costs over 5 years. (pending). Principal Investigator = M. Jenike. Ciba Neuroscience Fellowship. $25,000. 2/1/94-1/31/96. Ciba-Geigy Pharmaceutical Company. Principal Investigator = M. Jenike. Dista Neuroscience Fellowship. $5,000. 2/1/94-1/31/95. Eli Lilly Pharmaceutical Company.
Page 1 and 2: June 7, 2006 CURRICULUM VITAE Name:
Page 3 and 4: 3 1982-1984 Assistant in Psychiatry
Page 5 and 6: 5 1984-1987 American Psychiatric As
Page 7 and 8: 7 1987- Chairperson, Department of
Page 9 and 10: 9 1981- Massachusetts Psychiatric S
Page 11: 11 16. The International Journal of
Page 15 and 16: 15 Principal Investigator = M. Jeni
Page 17 and 18: 17 15. Kaufman MW, Cassem NH, Murra
Page 19 and 20: 19 43. Jenike MA, Armentano M, Baer
Page 21 and 22: 21 compulsive disorder. J Clin Psyc
Page 23 and 24: 23 94. Albert MS, Jenike MA, Nixon
Page 25 and 26: 25 116. Baer L, Cukor P, Jenike MA,
Page 27 and 28: 27 Savage CR, Caviness V, Jenike MA
Page 29 and 30: 29 of treatment, patient acceptance
Page 31 and 32: 31 Marked improvement in self-mutil
Page 33 and 34: 33 imaging study of regional cortic
Page 35 and 36: 35 227. Stewart ES, Platko J, Fager
Page 37 and 38: 37 23. Goff DC, Jenike MA. Treatmen
Page 39 and 40: 39 51. Jenike MA. Brain structural
Page 41 and 42: 41 19. Jenike MA. Anticholinergic d
Page 43 and 44: 43 43. Jenike MA. Alzheimer's disea
Page 45 and 46: 45 65. Jenike MA. Serotonin Augment
Page 47 and 48: 47 87. Jenike MA. Obsessive compuls
Page 49 and 50: 49 6. Stern TA, Jenike MA. Lithium
Page 51 and 52: 51 5. Jenike MA, Baer L, Minichiell
Page 53 and 54: 53 4. Sertraline OCD Study Group (C
Page 55 and 56: 55 23. Rauch SL, Alpert NM, Savage
Page 57 and 58: 57 41. Whalen PJ, Bush G, McNally R
Page 59 and 60: 59 a work in progress. American Ass
Page 61 and 62: 61 1983, 4/25 - Geriatric psychopha
Page 63 and 64:
63 1985, 6/23 - Alzheimer's disease
Page 65 and 66:
65 1986, 7/14 - Drug treatment of p
Page 67 and 68:
67 1986, 11/13 - New treatments of
Page 69 and 70:
69 1988, 3/19 - Practical Strategie
Page 71 and 72:
71 1988, 11/8 - Obsessive compulsiv
Page 73 and 74:
73 1990, 3/10 - Improved assessment
Page 75 and 76:
75 1991, 10/20 - Geriatric Psychoph
Page 77 and 78:
77 1992, 5/5 - New developments in
Page 79 and 80:
79 1993, 8/17, Better assessment an
Page 81 and 82:
81 1994, 7/6 - Pharmacotherapy of o
Page 83 and 84:
83 1995, 3/10 - Obsessive-compulsiv
Page 85 and 86:
85 1996, 4/27 - Obsessive-compulsiv
Page 87 and 88:
87 1997, 8/9 - Questions and answer
Page 89 and 90:
89 1999, 9/28 - Neurosurgical treat
Page 91 and 92:
91 2002, 3/2 - Geriatric Depression
show all

Michael A. Jenike - McLean Hospital - Harvard University

Create successful ePaper yourself

Delete template?

Save as template?